PL427652A1 - Układ elementu do wykonania zastawki serca, sposób wytwarzania zmodyfikowanej bakteryjnej celulozy (BC), zestaw oraz zastosowanie elementu do użycia w kardiochirurgii - Google Patents

Układ elementu do wykonania zastawki serca, sposób wytwarzania zmodyfikowanej bakteryjnej celulozy (BC), zestaw oraz zastosowanie elementu do użycia w kardiochirurgii

Info

Publication number
PL427652A1
PL427652A1 PL427652A PL42765218A PL427652A1 PL 427652 A1 PL427652 A1 PL 427652A1 PL 427652 A PL427652 A PL 427652A PL 42765218 A PL42765218 A PL 42765218A PL 427652 A1 PL427652 A1 PL 427652A1
Authority
PL
Poland
Prior art keywords
component
heart valve
arrangement
bacterial cellulose
cardiac surgery
Prior art date
Application number
PL427652A
Other languages
English (en)
Other versions
PL242163B1 (pl
Inventor
Piotr Siondalski
Magdalena KOŁACZKOWSKA
Waldemar WILANDT
Dariusz BOBIŃSKI
Aldona Długa
Kinga Dawidowska
Michał Ditrich
Leszek Wilczyński
Hanna Staroszczyk
Paulina DEDERKO
Edyta Malinowska-Pańczyk
Agata SOMMER
Izabela SINKIEWICZ
Ilona KOŁODZIEJSKA
Marek Szkodo
Alicja STANISŁAWSKA
Andrzej BORMAN
Artur Hugo Świergiel
Paulina PAŁCZYŃSKA
Grzegorz Jabłoński
Wojciech GLAC
Piotr Wilczek
Maciej GAWLIKOWSKI
Original Assignee
Gdański Uniwersytet Medyczny
Bowil Biotech Spółka Z Ograniczoną Odpowiedzialnością
Centrum Techniki Okrętowej Spółka Akcyjna
Politechnika Gdańska
Uniwersytet Gdański
Fundacja Rozwoju Kardiochirurgii Im. Profesora Zbigniewa Religi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gdański Uniwersytet Medyczny, Bowil Biotech Spółka Z Ograniczoną Odpowiedzialnością, Centrum Techniki Okrętowej Spółka Akcyjna, Politechnika Gdańska, Uniwersytet Gdański, Fundacja Rozwoju Kardiochirurgii Im. Profesora Zbigniewa Religi filed Critical Gdański Uniwersytet Medyczny
Priority to PL427652A priority Critical patent/PL242163B1/pl
Priority to EP19829703.8A priority patent/EP3876869B1/en
Priority to US17/291,248 priority patent/US20220001078A1/en
Priority to PCT/PL2019/000100 priority patent/WO2020096469A1/en
Publication of PL427652A1 publication Critical patent/PL427652A1/pl
Publication of PL242163B1 publication Critical patent/PL242163B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Przedmiotem zgłoszenia jest układ elementu do wykonania zastawki serca, sposób wytwarzania zmodyfikowanej bakteryjnej celulozy (BC) z wykorzystaniem szczepu Gluconacetobacter xylinus do wytwarzania elementu do wykonania zastawki serca, zestaw do wszczepiania oraz zastosowanie elementu do użycia w kardiochirurgii.
PL427652A 2018-11-05 2018-11-05 Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu PL242163B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL427652A PL242163B1 (pl) 2018-11-05 2018-11-05 Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu
EP19829703.8A EP3876869B1 (en) 2018-11-05 2019-11-05 The system of an element used for the creation of heart valve, the method of manufacturing of modified bacterial cellulose (bc), the set and the element used in cardio surgery
US17/291,248 US20220001078A1 (en) 2018-11-05 2019-11-05 The system of an element used for the creation of heart valve, the method of manufacturing of modified bacterial cellulose (bc), the set and the element used in cardio surgery
PCT/PL2019/000100 WO2020096469A1 (en) 2018-11-05 2019-11-05 The system of an element used for the creation of heart valve, the method of manufacturing of modified bacterial cellulose (bc), the set and the element used in cardio surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL427652A PL242163B1 (pl) 2018-11-05 2018-11-05 Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu

Publications (2)

Publication Number Publication Date
PL427652A1 true PL427652A1 (pl) 2020-05-18
PL242163B1 PL242163B1 (pl) 2023-01-23

Family

ID=69063849

Family Applications (1)

Application Number Title Priority Date Filing Date
PL427652A PL242163B1 (pl) 2018-11-05 2018-11-05 Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu

Country Status (4)

Country Link
US (1) US20220001078A1 (pl)
EP (1) EP3876869B1 (pl)
PL (1) PL242163B1 (pl)
WO (1) WO2020096469A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL242163B1 (pl) * 2018-11-05 2023-01-23 Bowil Biotech Spolka Z Ograniczona Odpowiedzialnoscia Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu
US11620979B2 (en) * 2019-12-18 2023-04-04 Google Llc Dynamic tempered sampling in generative models inference

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6328763B1 (en) * 1995-10-06 2001-12-11 Cardiomend, Llc Optimized geometry of a tissue pattern for semilunar heart valve reconstruction
WO2013119912A1 (en) * 2012-02-10 2013-08-15 The University Of Iowa Research Foundation Vascular prosthetic assemblies
US9101469B2 (en) * 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
EP3572043B1 (en) * 2018-05-23 2023-08-16 Biotronik Ag Medical implant with seamlessly connected bacterial cellulose
PL242163B1 (pl) * 2018-11-05 2023-01-23 Bowil Biotech Spolka Z Ograniczona Odpowiedzialnoscia Element do wykonania zastawki serca oraz sposób wytwarzania zmodyfikowanej bakteryjnej celulozy do wytwarzania tego elementu

Also Published As

Publication number Publication date
EP3876869A1 (en) 2021-09-15
EP3876869B1 (en) 2024-09-25
US20220001078A1 (en) 2022-01-06
WO2020096469A1 (en) 2020-05-14
PL242163B1 (pl) 2023-01-23

Similar Documents

Publication Publication Date Title
AU2019205319A8 (en) Heart valve prosthesis and delivery
EP4516241A3 (en) Annuloplasty implant
EP4483845A3 (en) Leaflet extension for cardiac valve leaflet
EP4446363A3 (en) Dermal fillers and applications thereof
HK1220103A1 (zh) 可扩展的可植入导管
WO2019175911A3 (en) Mesh or membrane covering for prostheses made of biologic or biosynthetic material, comprising a system for fixation to the prosthesis, and corresponding manufacturing method
AU2018268369A1 (en) Articulated prosthesis for a tricuspid or mitral valve and related catching device
AU2018335389A1 (en) Nanofiber structures and methods of use thereof
TWD236458S (zh) 連接器
EP3718483A3 (en) Tissue augmentation scaffolds for use with soft tissue fixation repair systems
MX2020000190A (es) Métodos para tratar la insuficiencia cardíaca con activadores de sarcómero cardíaco.
MX2021001036A (es) Extractos botanicos y bacterianos que muestran actividad similar al retinol.
MX2020012018A (es) Composiciones para el tratamiento de condiciones de la piel.
EP4484443A3 (en) Materials and methods for treatment of friedreich ataxia and other related disorders
WO2018217710A8 (en) Micro-nanobubble solutions for tissue preservation and generation thereof
MX2021003180A (es) Métodos y kits para preparar sangre entera con inactivación de patógenos.
BR112021023029A2 (pt) Células, tecidos, órgãos e/ou animais tendo um ou mais de genes modificados para sobrevivência e/ou tolerância de xenoenxerto potencializada(s)
WO2022245977A3 (en) Methods for the expansion of human granulocytemacrophage progenitors and applications thereof
EP4585235A3 (en) Textured medical textiles
WO2020049552A9 (en) Tissue repair by activated cells
AU2018279738A1 (en) Methods of enhancing development of renal organoids and methods of using the same
MX2021005157A (es) Composiciones, metodos para hacer y utilizar extracto de salvado de arroz.
EP4397752A3 (en) Methods for obtaining induced smooth muscle cells
WO2020086954A3 (en) Treatments for charcot-marie-tooth disease
EP4150059A4 (en) ANTIGEN-PRESENTING T-CELLS, SENSITIZED, ENGINEERED T-CELLS AND TREATMENT METHODS THEREOF